4.1 Common Medication-Related Problems Overview

Common Medication-Related Problems Overview

Quick Answer: Medication-related problems (MRPs) are drug therapy issues that can prevent optimal outcomes. In MTM, pharmacists classify them mainly by indication, effectiveness, safety, and adherence. Technicians screen for signals—late refills, cost concerns, side-effect comments, missing indicated drugs—and flag them for pharmacist review.

Domain 1 of the PTCB Medication Therapy Management Certificate expects you to recognize common medication-related problems. You are not the clinician who finalizes the assessment, but you are often the first person who notices that something in the profile, refill history, or patient story does not add up. Strong screening turns a routine refill or CMR intake into a high-value Targeted Medication Review (TMR) or Comprehensive Medication Review (CMR) finding.

---

The Pharmacotherapy Workup Frame (What Pharmacists Assess)

A widely taught MRP framework (Cipolle/Strand/Morley and related pharmacotherapy workup models) groups drug therapy problems into four buckets:

Exam takeaway: when a question asks for hallmark MRP categories assessed during an MTM visit, think indication, effectiveness, safety, and adherence—not billing codes or shipping methods.

These categories overlap in real life. A patient who stops a statin because of muscle aches has a safety concern that drove an adherence problem and may create an indication/effectiveness gap if LDL control worsens. Your job is to capture the story cleanly so the pharmacist can sort the primary problem.

---

Four High-Yield Problems Technicians Screen Every Day

The official outline highlights everyday problems you will see in community, ambulatory, and Part D MTM workflows. Focus your screening energy here:

1. Side effects and adverse reactions

Patients often volunteer symptoms before they volunteer adherence problems: "That blood pressure pill makes me cough," "The diabetes medicine wrecks my stomach," "My legs cramp since the water pill." Side effects can be expected (metformin GI upset early on) or serious red flags (dark urine and muscle pain on a statin suggesting rhabdomyolysis). Document drug, timing relative to start/dose change, severity, and what the patient did (stopped, reduced, continued).

2. Nonadherence

Nonadherence includes late refills, skipped doses, partial fills that never continue, controller inhalers unused while rescue inhalers are overused, and primary nonadherence (prescription written but never picked up). Claims-based patterns such as repeatedly filling five days late are classic technician flags for pharmacist adherence counseling or TMR.

3. Affordability barriers

Cost is one of the most common reasons patients ration or abandon therapy. A fixed-income patient who skips brand-name anticoagulant doses to "make the bottle last" has an adherence problem driven by affordability—not a mysterious clinical failure. Capture exact language about cost, which drug, and what the patient is doing (splitting tablets, stretching days, skipping).

4. Gaps in therapy

A gap in therapy (untreated indication / needs additional therapy) means a recommended treatment is missing. Examples: no statin in a 65-year-old with type 2 diabetes and ASCVD; no ACE inhibitor/ARB when guidelines and the pharmacist's assessment support one; missing inhaler controller when diagnosis and symptoms suggest need. Gaps are often invisible in refill history because there is nothing to refill—you find them by comparing conditions + guidelines/indications to the medication list.

---

How Technicians Screen Without Crossing the Clinical Line

Screen means systematically looking for mismatches and patient-reported problems. Assess and intervene clinically belongs to the pharmacist (or other qualified provider). Stay on the right side of that line:

Appropriate technician screening moves

1. Pull and organize the full medication list (Rx, OTC, herbals, supplements).
2. Compare refill timing and days' supply patterns for chronic meds.
3. Ask open intake questions: "Any medicines you skip or stretch? Any side effects that worry you? Any costs making it hard to pick up?"
4. Note allergies/intolerances with reaction detail (covered deeply in Chapter 3).
5. Attach available labs (A1C, potassium, blood pressure logs) to the packet for pharmacist review.
6. Draft a clear flag in the workflow tool: what you saw, where you saw it, and how urgent it feels.

Inappropriate technician moves

• Telling the patient to stop a medicine, change the dose, or switch classes
• Reassuring that a serious symptom is "normal" without pharmacist assessment
• Ignoring high-risk comments (bleeding on anticoagulant, chest pain, severe rash, dark urine with muscle pain)
• Filing a clinical recommendation to the prescriber under your own authority

Scenario — Late Refills Become an MRP Flag

Tech reviewing claims: metformin 500 mg BID, 30-day supply, filled on days 1, 36, 71, and 106 of a measurement window—about five days late each cycle. Tech action: Flag recurring late refills as a possible adherence MRP; note approximate pattern; alert pharmacist for TMR or adherence counseling. Why it matters: Consistent late fills pull Proportion of Days Covered (PDC) down and can push the patient below the common 80% adherence threshold used in quality measures.

Scenario — Cost Rationing on a High-Risk Drug

Patient: "I only take my brand blood thinner every other day so the bottle lasts." Tech: "Thank you for telling me—that helps us keep you safe. I'm going to document that cost is making it hard to take this blood thinner every day and get the pharmacist involved right away. Please don't change how you take it further until they speak with you."

That response validates the patient, classifies the issue as affordability-driven nonadherence, and escalates a high-risk therapy without unauthorized clinical advice.

---

Where MRPs Sit in the MTM Workflow

MRP identification is the clinical engine of the Medication Therapy Review (MTR). Findings flow into:

• Personal Medication Record (PMR) — accurate current list and allergy/problem notes
• Medication-related Action Plan (MAP) — patient-friendly actions addressing prioritized problems
• Intervention and/or referral — pharmacist-to-prescriber recommendations, counseling, or outside referral
• Documentation and follow-up — what was found, what was done, and when to check again

Technicians who consistently surface side effects, nonadherence, affordability barriers, and therapy gaps make the pharmacist faster and the patient safer. On the exam and on the job, remember: spot and flag early; do not silently treat.